Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Details : Under terms of the partnerships, Orange Grove Bio will work with YUHS and POSTECH to advance the development and commercialization of novel therapeutics in the areas of oncology, as well as autoimmune and inflammatory diseases.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
March 23, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Study Phase : Preclinical
Sponsor : Cincinnati Children’s Hospital Medical Center
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Under the collaboration, Orange Grove Bio will provide commercialization guidance and support to Cincinnati Children’s Innovation Ventures. Orange Grove Bio’s chief will advise on potential of emerging technologies from the Cincinnati Children’s In...
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
September 03, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Highest Development Status : Preclinical
Sponsor : Cincinnati Children’s Hospital Medical Center
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Through the newly established program, Einstein scientists will have the opportunity to receive expert mentorship and financial support to advance their foundational research and streamline translation of their discoveries into new drug candidates.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
October 21, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Study Phase : Discovery
Sponsor : Viva BioInnovator
Deal Size : $10.0 million
Deal Type : Financing
Details : Proceeds from the financing will support the company’s continued advancement of its lead drug candidates toward first-in-human clinical studies, including submission of the company’s first investigational new drug (IND) application.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
May 10, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Highest Development Status : Discovery
Sponsor : Viva BioInnovator
Deal Size : $10.0 million
Deal Type : Financing
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Study Phase : Preclinical
Sponsor : Viva BioInnovator
Deal Size : $10.0 million
Deal Type : Financing
Details : Proceeds from the financing will support the company’s continued advancement of its lead drug candidates toward first-in-human clinical studies, including submission of the company’s first investigational new drug (IND) application.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
May 10, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Highest Development Status : Preclinical
Sponsor : Viva BioInnovator
Deal Size : $10.0 million
Deal Type : Financing